RxDoctor Payments Data

Arnold Shapiro, MD

Psychiatry · Ft Wright, KYNPI 1568508158

Payments from drug & device makers

$3,250in general payments, 2019–2025

Across 68 payments — averaging $47.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Supernus Pharmaceuticals, Inc.$615
  • Ironshore Pharmaceuticals Inc.$359
  • Otsuka America Pharmaceutical, Inc.$142
  • Johnson & Johnson$137
  • Neurocrine Biosciences, Inc.$83
  • plus $178 from 4 others

What the payments were for

  • Speaking & faculty fees$1,80055%
  • Food & beverage$1,40043%
  • Education$492%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,250 in reported general payments places this provider in the 80th percentile of 348 psychiatry providers in Kentucky.

See all psychiatry providers in Kentucky

Medicare billing

Part B allowed, 2024
$23,720
Medicare patients
21
Services billed
304

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CaplytaLumateperone Tosylate16$29,003
Lurasidone Hcl30$8,015
Adderall XrDextroamphetamine/Amphetamine11$4,458
DayvigoLemborexant13$4,288
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine19$2,121
Modafinil24$1,549
Carbamazepine ErCarbamazepine15$1,275
Vilazodone Hcl14$1,119
Aripiprazole37$985
Quetiapine Fumarate77$728
Lamotrigine82$670
Duloxetine Hcl22$537
Dextroamphetamine Sulfate ErDextroamphetamine Sulfate11$495
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine33$484
Alprazolam36$391

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$47$29,00316 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 348 psychiatry providers in Kentucky.

Other psychiatry in Ft Wright

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →